Correctional Officer II

class II antigen [ class II MHC molecule ]

certified level II dental assistant

angiotensin II AT1 receptor blocker | angiotensin II type 1 receptor antagonist

nicotinamide adenine dinucleotide phosphate | NADP | NADP+ | TPN+ | triphosphopyridine nucleotide | coenzyme II | codehydrogenase II

type II hypersensitivity reaction | cytotoxic reaction | antibody-mediated hypersensitivity | cytolytic reaction

Political Affairs Division II, Africa, Middle East

Political Affairs Division II, Asia-Pacific

upper secondary

Atrioventricular block, type I and II Möbitz block, type I and II Second-degree block, type I and II Wenckebach's block

(Return tabled) Question No. 4 Hon. Irwin Cotler: With regard to international treaties and conventions dealing in whole or in part with human rights and with Canada’s international obligations in this regard: (a) does the government have any formal or informal procedures for regular review of those international human rights treaties that Canada has not yet signed, ratified, or otherwise accepted; (b) does the government have any formal or informal guidelines according to which it determines whether the specific obligations contained in a treaty or other international undertaking conflicts with the Constitution Act, 1867, and if so where can these guidelines be accessed; (c) do the guidelines referred to in (b) specify the standard accor ...[+++]ding to which the government determines if any obligation contained in a treaty or other international undertaking violates any section of the Constitution Act, 1867; (d) has the government engaged in any review of its obligations under the Convention on the Elimination of Racial Discrimination (CERD); (e) does the government have any formal or informal guidelines according to which it determines whether the specific obligations contained in a treaty or other international undertaking require implementing legislation in order for Canada to be able to ratify or otherwise accept it, and if so where can these guidelines be accessed; (f) does the government have a position as to whether international agreements that establish a complaints mechanism or communications procedure for enforcement of the rights and obligations contained therein are necessarily unconstitutional; (g) does the government have a policy as to whether Canada will accept such agreements referred to in (f); (h) does the government undergo review of proposed international human rights agreements that would establish such a mechanism or procedure referred to in (f) on a case by case basis, (i) who is involved in this review, (ii) are the provinces and other inte ...

With regard to (ii), Environment Canada has no database that records project-specific staff time costs.

Question No. 51 Ms. Kirsty Duncan With regard to the development of greenhouse gas regulations for the oil and gas sector: (a) what is the total of all relevant government expenditures related to the activities of the Process Working Group (PWG) including, but not limited to, (i) travel expenses (transportation, accommodation, rental of meeting spaces or equipment, food, and other travel-related expenses), (ii) staff time costs, including any overtime pay incurred, (iii) any services or other support procured from consultants or other contractors, (iv) other relevant expenses incurred, with a break-down of all related details; (b) in ad ...[+++]dition to those expenditures incurred through the operations of the PWG, what are any other government expenditures regarding consultation, discussion, engagement or negotiation with oil and gas sector companies including, but not limited to, (i) travel expenses (transportation, accommodation, rental of meeting spaces or equipment, food, and other travel-related expenses), (ii) staff time costs, including any overtime pay incurred, (iii) any services or other support procured from consultants or other contractors, (iv) other relevant expenses incurred, with a break-down of all related details; (c) in addition to those expenditures incurred through the operations of the PWG, what are any other government expenditures, regarding consultation, discussion, engagement or negotiation with oil and gas sector industry associations including, but not limited to, (i) travel expenses (transportation, accommodation, rental of meeting spaces or equipment, food, and other travel-related expenses), (ii) staff time costs, including any overtime pay incurred, (iii) any services or other support procured from consultants or other contractors, (iv) other relevant expenses incurred, with a break-down of all related details; (d) in addition to those expenditures incurred through the operations of the PWG, what are any other government expenditures, reg ...

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and t ...[+++]reatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) how is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...